Related Experiment Video
Updated: Dec 20, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Indoor microbiome and risk of lower respiratory tract infections among children under-five years: A meta-analysis
Adekunle G Fakunle1,2, Nkosana Jafta1, Akinkunmi P Okekunle3,4
1Discipline of Occupational and Environmental Health, University of KwaZulu-Natal, Durban, South Africa.
Insights
Exposure to indoor microbiome (IM) increases the risk of lower respiratory tract infections (LRTI) in young children. Higher fungal concentrations pose a greater risk, suggesting interventions for IM exposure are crucial for managing LRTI.
Area of Science:
- Environmental Health
- Pediatric Infectious Diseases
- Microbiology
Background:
- Indoor environments harbor diverse microbiomes.
- Exposure to indoor microbiome (IM) is a potential risk factor for respiratory illnesses in children.
- Lower respiratory tract infections (LRTI) are a significant cause of morbidity in children under five.
Purpose of the Study:
- To investigate the association between indoor microbiome exposure and the risk of LRTI in children under five.
- To conduct a meta-analysis of existing studies quantifying this relationship.
Main Methods:
- A systematic literature search was performed across multiple electronic databases (PubMed, Scopus, Web of Science, GreenFILE, EMBASE, Cochrane Library) up to July 2019.
- Eligible studies reported adjusted risk measures (RR or OR with CI) for LRTI associated with IM exposure.
- A meta-analysis pooled the odds ratios (OR) using the inverse of variance method, with sensitivity and heterogeneity analyses.
Main Results:
- Seven studies were included in the meta-analysis.
- Higher concentrations of indoor microbiome were significantly associated with an increased risk of LRTI (OR: 1.20, P < .0001).
- Exposure to total fungal concentration showed a stronger association with LRTI risk (OR: 1.27, P < .0001) compared to visible molds (OR: 1.20, P = .001).
Conclusions:
- Children under five exposed to higher indoor microbiome concentrations are at increased risk of developing LRTI.
- Interventions aimed at reducing indoor microbiome exposure should be considered in the prevention and management of LRTI in young children.
Abstract:
We investigated whether exposure to microbiome within the indoor environment is associated with risk of lower respiratory tract infections (LRTI) among children under 5 years of age. Electronic scientific repositories; PubMed, Scopus, Web of Science, GreenFILE, EMBASE, and Cochrane library were searched and screened through July 2019 for published reports for inclusion in the meta-analysis. Studies were eligible for inclusion if they reported an adjusted measure of risk for LRTI associated with IM exposure, including the relative risk (RR) or odds ratio (OR) and confidence interval (CI). The pooled OR was computed using the inverse of variance method for weighting. Sensitivity analysis was used to evaluate the effect of individual studies, while heterogeneity was evaluated by I2 statistics using RevMan 5.3. Seven studies were eligible for inclusion in our meta-analysis. Exposure to a higher concentration of IM was associated with an increased risk of LRTI [OR:1.20 (1.11, 1.33), P < .0001]. The risk was stronger with exposure to total fungal concentration [OR:1.27 (1.13, 1.44), P < .0001] than visible molds [OR:1.20 (1.07, 1.34, P = .001]. Under-five children exposed to higher IM concentration are likely at increased risk of LRTI. Interventions addressing IM exposure should be considered in the management of LRTI among under-five children.
Related Concept Videos
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Asthma-I: Introduction
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...

